Glenmark Pharmaceuticals Inc USA data breach

Clerk's notes

Glenmark Pharmaceuticals Inc USA, based in Indiana, has formally reported a data breach incident. The company identified an event on February 27, 2026, that may have compromised certain personal information. This incident was subsequently filed with authorities on March 17, 2026, and is presently under investigation.

The specific categories of information involved in this breach have not been detailed. However, it has been confirmed that personal information was affected. This means that individuals whose data was compromised could face various risks depending on the nature of the information involved.

For those who have received a notification letter from Glenmark Pharmaceuticals Inc USA, it is important to review the communication carefully. While the company is actively investigating, affected individuals should consider taking proactive steps to protect themselves from potential misuse of their data.

General protective measures can include monitoring your accounts for unusual activity and being vigilant against unexpected communications. Remaining informed about the status of the investigation is also advisable, as more details may emerge regarding the scope and impact of the breach.

If you believe your personal information was exposed in the Glenmark Pharmaceuticals Inc USA data incident, you may be eligible to pursue a claim. Our firm is currently reviewing this matter to assess potential legal avenues for affected individuals. Requesting a free case review can help you understand if your situation warrants further action. This is attorney advertising and does not guarantee a specific outcome.

If a notification letter about this breach reached you, see every IN data breach on file or browse all cases.